Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCahaba Wealth Management, Inc.
Latest Disclosed Ownership637 shares
Latest Disclosed Value $ 224,050
Cahaba Wealth Management, Inc. reports 9.65% decrease in ownership of AMGN / Amgen Inc.

On April 29, 2026 - Cahaba Wealth Management, Inc. filed a 13F-HR form disclosing ownership of 637 shares of Amgen Inc. (MX:AMGN) valued at $224,050 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 705 shares of Amgen Inc.. This represents a change in shares of -9.65% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F AMGEN COM 031162100 637 -68 -9.65 224 -2.61 0.0152
2026-01-07 2025-12-31 13F AMGEN COM 031162100 705 -11 -1.54 231 13.86 0.0161
2025-10-17 2025-09-30 13F AMGEN COM 031162100 716 -140 -16.36 202 -15.48 0.0146
2025-07-16 2025-06-30 13F AMGEN COM 031162100 856 -131 -13.27 239 -22.15 0.0186
2025-05-01 2025-03-31 13F AMGEN COM 031162100 987 10 1.02 307 20.87 0.0254
2025-02-13 2024-12-31 13F AMGEN COM 031162100 977 1 0.10 255 -19.11 0.0211
2024-10-18 2024-09-30 13F AMGEN COM 031162100 976 0 0.00 315 3.29 0.0260
2024-08-05 2024-06-30 13F AMGEN COM 031162100 976 -87 -8.18 305 0.66 0.0269
2024-04-22 2024-03-31 13F AMGEN COM 031162100 1,063 0 0.00 302 -1.31 0.0275
2024-01-23 2023-12-31 13F AMGEN COM 031162100 1,063 -114 -9.69 306 -3.16 0.0304
2023-10-18 2023-09-30 13F AMGEN COM 031162100 1,177 -627 -34.76 316 -21.00 0.0349
2023-07-26 2023-06-30 13F AMGEN COM 031162100 1,804 -107 -5.60 401 -13.42 0.0433
2023-05-04 2023-03-31 13F AMGEN COM 031162100 1,911 -20 -1.04 462 -8.88 0.0528
2023-01-30 2022-12-31 13F AMGEN COM 031162100 1,931 -56 -2.82 507 13.42 0.0629
2022-10-19 2022-09-30 13F AMGEN INC COM COM 031162100 1,987 14 0.71 447 -6.87 0.0618
2022-07-19 2022-06-30 13F AMGEN INC COM COM 031162100 1,973 -160 -7.50 480 -3.42 0.0685
2022-05-05 2022-03-31 13F AMGEN INC COM COM 031162100 2,133 -227 -9.62 497 -6.40 0.0682
2022-02-01 2021-12-31 13F AMGEN INC COM COM 031162100 2,360 435 22.60 531 29.83 0.0704
2021-10-15 2021-09-30 13F AMGEN INC COM COM 031162100 1,925 1,925 409 0.0602
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.